Using a unique transgenic research tool allowed for conditional transgenic manipulations of VEGF in the brain, suitable for VEGF gain-of-function (GOF) or, for VEGF loss-of-function (LOF), both in a reversible manner [30], we demonstrated that overexpressing VEGF prior to stroke protects the brain from stroke-induced damages. Here, VEGFA is linked to stroke disorder.